Category: Uncategorized

USING THOUGHTS TO MAKE ACTS through brain computer interfacing and robotics is a dramatic advance for paralyzed patients. How many other applications does this approach have? Could a thought be propelled into action on the other side of the world remotely? http://lnkd.in/iqy8xt View in LinkedIn

NEW EARLY STAGE BIOTECH FUND. View in LinkedIn

THE NEED FOR A COLD CHAIN FOR DEVELOPING COUNTRIES VACCINES is a significant obstacle for healthcare initiatives. It also contributes about 80% of the cost. Remember that Next Generation DNA VACCINES do not require a cold chain, and can be delivered nasally, making delivery significantly less challenging. View in LinkedIn

CHINA'S INTEREST IN BIOTECH DRUGS IS SPURRING INVESTMENTS. Capable of implementing very long-term and well-funded initiatives, China is becoming an influential player in world investment markets. The JPM breakout session a couple of years ago featured Chinese Pharma companies talking about brand drugs. This was a significant sea change, because it meant that they would enforce patent protection. Watch this space. http://lnkd.in/Swa-RQ View in LinkedIn

"CAN YOU MAKE GUMBOOTS FOR FROGS OUT OF THIS?" my old chemistry professor used to say. This memorably zany question stuck front and central un my brain thereafter. It was a repurposing question before we were using the word repurposing. Taffy's great article highlights the benefits of repurposing beyond pharmaceuticals. http://lnkd.in/umerTY View in LinkedIn

THE BEIJING GENOMICS INSTITUTE, with a whopping 4,000 staff and a massive 1.58 B USD funding, is a phenomenal undertaking. Symbolic of the future power of DNA sequencing and its applications, it gives a boost to biotech worldwide. The time for harnessing international collaborations with such giants is now. http://lnkd.in/WK9r-g View in LinkedIn

0 View in LinkedIn

WESTERN PHARMA's R&D MODEL is clearly broken, so just ranking highly for throwing capital at a research organization is not impressive. Better to see that capital divided into numerous outsourced financings with small innovative companies, who are infinitely mire productive and imaginative. http://m.timesofindia.com/business/india-business/Indian-companies-top-global-charts-for-investment-in-RD/articleshow/18099909.cms View in LinkedIn

0 View in LinkedIn

PATIENT OUTCOMES are becoming an important metric for new drugs, and long overdue. Gatekeeping of a successful medicine has shifted in recent years from the FDA to payers, and pharmacoeconomics, as the UK's NICE committee has recently demonstrated in exclusion decisions for expensive drugs. http://lnkd.in/dejJgi View in LinkedIn